Evaluating Near-Infrared Autofluorescence for Parathyroid Preservation in Total Thyroidectomy: Long-Term Outcomes from a Prospective Randomized Trial

Evaluating Near-Infrared Autofluorescence for Parathyroid Preservation in Total Thyroidectomy: Long-Term Outcomes from a Prospective Randomized Trial

This two-center randomized trial assessed near-infrared autofluorescence imaging to identify parathyroid glands during total thyroidectomy. Despite higher gland identification rates, the technology did not reduce hypoparathyroidism incidence at 3 and 12 months postoperatively.
Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial

Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial

The phase 3 TORCH trial demonstrates that adding selective radiofrequency ablation after transarterial chemoembolization significantly improves progression-free and overall survival in patients with unresectable liver-confined hepatocellular carcinoma, with acceptable safety.